Aiko Ogasawara

3PUBLICATIONS
24CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 23, 2025
Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models.

Shigehiro Yagishita, Sho Sato, Daisuke Shintani

|Aug 12, 2024
Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential.

Sho Sato, Takahito Miura, Aiko Ogasawara

|Oct 20, 2020
High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.

Yuji Ikeda, Sho Sato, Akira Yabuno

Pageof 1

Frequent Collaborators

3 joint publications

Sho Sato

3 joint publications

Daisuke Shintani

3 joint publications

Kosei Hasegawa

1 joint publications

Yuji Ikeda